Optima Living, Axium Infrastructure and Desjardins Global Asset Management Announce Acquisition of Five Seniors Living and Continuing Care Communities from The Brenda Strafford Foundation
Edmonton, Alberta--(Newsfile Corp. - October 6, 2026) - Optima Living ("Optima" or "Optima Living"), Axium Infrastructure, via one of its managed funds ("Axium"), and DGAM Global Private Infrastructure Fund ("DGAM Infrastructure Fund") managed by Desjardins Global Asset Management Inc., are pleased to announce the acquisition of five seniors living and continuing care communities from The Brenda Strafford Foundation ("BSF") in Calgary and Okotoks, Alberta: Bow View Manor, Cambridge Manor, Cl
2026-10-06 10:00 AM EDT | Optima Seniors Management Inc.
Adia Med Partners with Live Oak Health (dba QCM Biologics) as Distributor and Sells 30% Stake in Adia Labs for $1.5 Million
Winter Park, Florida--(Newsfile Corp. - October 6, 2026) - Adia Med Inc. (OTCQB: ADIA) today announced that it has sold a 30% interest in Adia Labs LLC to Live Oak Health, a stem cell distributor doing business as QCM Biologics, for $1.5 million, and that the sale is paired with a distribution partnership. The Company has filed a Form 8-K related to the transaction. Link to Form 8-K here: Inline Viewer: ADIA MED, INC. 8-K 2026-
Healthcare and Hospitals, Health
2026-10-06 9:20 AM EDT | Adia Med Inc.
Phio Pharmaceuticals to Present at The Global Markets Virtual Forum October 8, 2026
King of Prussia, Pennsylvania--(Newsfile Corp. - October 6, 2026) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage biotechnology company developing cancer therapeutics based on its proprietary INTASYL® siRNA gene-silencing platform, today announced that Robert Bi
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2026-10-06 7:00 AM EDT | Phio Pharmaceuticals Corp.
HEALWELL AI Provides Research Update on Peer-Reviewed MyHealthNB Study and Global Recognition of DARWEN(TM)
Peer-reviewed research published in the Journal of Medical Internet Research (JMIR) reports that VeroSource's MyHealth patient app was associated with statistically significant, self-reported improvements in patient empowerment and healthcare engagement. HEALWELL's DARWEN™ AI abstract was selected as one of just 10 additional submissions to be featured in the HealthAI Global Governance Forum 2026's "Beyond the Room" digital programme. Toronto, Onta
Technology, Healthcare and Hospitals
2026-10-06 6:00 AM EDT | HEALWELL AI
WELLSTAR to Open the Market at the TSX on October 7, 2026, and Introduces Senior Leadership Team
Vancouver, British Columbia--(Newsfile Corp. - October 6, 2026) - WELLSTAR Technologies Corp. (TSXV: WSTR)
Technology, Healthcare and Hospitals
2026-10-06 6:00 AM EDT | WELLSTAR Technologies Corp.
Extendicare Announces Timing of 2026 Third Quarter Results and Conference Call
Markham, Ontario--(Newsfile Corp. - October 5, 2026) - Extendicare Inc. (TSX: EXE) ("Extendicare" or the "Company") announced today that it plans to release its financial results for the third quarter of 2026 after market close on Thursday, November 5, 2026. A conference call hosted by Michael Guerriere, President and Chief Executive Officer and David Bacon, Executive Vice President and Chief Financial Officer, will be held on Friday, November 6, 2026, at 11:30 a.m. (EST) to discuss the
Healthcare and Hospitals, Pharmaceuticals, Health
2026-10-05 8:00 AM EDT | Extendicare Inc.
Phio Pharmaceuticals to Present at the National Investment Banking Association (NIBA) 153rd Conference
King of Prussia, Pennsylvania--(Newsfile Corp. - October 5, 2026) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage biotechnology company developing cancer therapeutics based on its proprietary INTASYL® siRNA gene-silencing platform, today announced that it has accepted the invitation to present at the National Investment Banking Association's (NIBA) 153rd Conference on October 6-7, 2026, in Fort Lauderdale, Florida. Robert Bitterman, President and Chief Executive Offic
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2026-10-05 7:00 AM EDT | Phio Pharmaceuticals Corp.
Healthcare Special Opportunities Fund Announces Final Distribution
Toronto, Ontario--(Newsfile Corp. - October 1, 2026) - LDIC Inc. (the "Manager"), manager and trustee of Healthcare Special Opportunities Fund (the "Fund"), formerly listed on the Toronto Stock Exchange under the ticker MDS.UN, today announced the final distribution to unitholders pursuant to the previously announced proposal to transfer the Fund's remaining private investments to Healthcare Special Opportunities Sidecar LP (the "Sidecar LP") and terminate the Fund.
Banking / Financial Services, Healthcare and Hospitals
2026-10-01 2:14 PM EDT | Healthcare Special Opportunities Fund
Launchit Solutions and the Sleep Endoscopy Centre Launch Shared Care Partnership for Obesity and Sleep Apnea
Ontario and Vaughan, Ontario--(Newsfile Corp. - October 1, 2026) - Launchit Solutions Inc. (Launchit), which built and operates the Medical Weight Management Centre (MWM) virtual obesity clinic, and the Sleep Endoscopy Centre for Snoring and Sleep Apnea (SEC) today announced a shared care partnership. The partnership connects MWM patients to OSA assessment and treatment at SEC, and connects SEC patients to obesity assessment and treatment at MWM. Obesity and obstructive sleep
Technology, Computer Software, Healthcare and Hospitals
2026-10-01 7:30 AM EDT | Launchit Solutions Inc.
WELLSTAR Commences Trading on TSX Venture Exchange and Announces Its Board of Directors
WELLSTAR commences trading on the TSX Venture Exchange at the market open on October 1, 2026, under the ticker symbol "WSTR". The Company also announces the five-member Board of Directors will be led by Hamed Shahbazi (Chairman), Amir Javidan, Evelyn Sutherland, Matt Mattox and Sue Paish. WELLSTAR's Board of Directors combines healthcare, technology, capital markets and governance experience to support WELLSTAR's next phase of growth.
Technology, Healthcare and Hospitals
2026-10-01 6:00 AM EDT | WELLSTAR Technologies Corp.
Aurora Spine Corporation Announces Amendment to Loan from Insider
Carlsbad, California--(Newsfile Corp. - September 29, 2026) - Aurora Spine Corporation (TSXV: ASG) ("Aurora Spine" or the "Company") announced today that an insider of the Company has agreed to increase the principal amount available under an existing loan with the Company (the "Loan") by US$200,000. As a result of this increase, the total principal amount owing by the Company to the insider is US$2.4 million (the "Principal Amount"). The Company intends to use the Loan proce
2026-09-29 6:53 PM EDT | Aurora Spine Corporation
WELL Health Subsidiary WELLSTAR Announces Completion of Amalgamation and Expected Trading Date of "WSTR" on TSXV
Vancouver, British Columbia--(Newsfile Corp. - September 29, 2026) - WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) ("WELL"), a digital health company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to announce that its subsidiary, WELLSTAR Technologies Corp. ("WELLSTAR") has completed the previously announced amalgamation (the "Transaction") with 1587818 B.C. L
Technology, Computer Software, Healthcare and Hospitals, Health
2026-09-29 3:30 PM EDT | WELL Health Technologies Corp.
Adia Med Inc. Announces Adia Labs Expansion of Regenerative Product Line
Winter Park, Florida--(Newsfile Corp. - September 29, 2026) - Adia Med Inc. (OTCQB: ADIA), a regenerative medicine company focused on stem cell therapies, biologics, and physician-supervised investigational research, today announced that its laboratory subsidiary, Adia Labs LLC, has expanded its product portfolio with three new research-use offerings: Adia30M, AdiaClear, and AdiaEXO.
Healthcare and Hospitals, Health
2026-09-29 8:00 AM EDT | Adia Med Inc.
KALA Bio Signs Non-Binding LOI to Acquire Nationwide Telehealth Platform with Approximately $48 Million in Sales Since Inception
Key Highlights Target generated approximately $12.7 million in revenue for the trailing twelve months ended August 2026 (unaudited, as provided by Target management) and is cash-flow positive Proposed purchase price of approximately $15 million, payable in cash and KALA stock; the cash portion is expected to be funded from existing balance sheet resources Founded in 2023; LegitScript-certified, NABP-accredited platform serving clients in all
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2026-09-29 7:30 AM EDT | KALA Bio Inc.
WELL Health Subsidiary WELLSTAR Announces Conditional Approval for TSXV Listing and Files Filing Statement
Vancouver, British Columbia--(Newsfile Corp. - September 28, 2026) - WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) ("WELL"), a digital health company focused on positively
Technology, Computer Software, Healthcare and Hospitals, Health
2026-09-28 6:00 AM EDT | WELL Health Technologies Corp.
Medexus Holds Annual Meeting of Shareholders and Announces Election of Directors
Ontario and Chicago, Illinois--(Newsfile Corp. - September 24, 2026) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) today held its virtual annual meeting of shareholders. Medexus shareholders elected all nominees listed in Medexus's management information circular dated August 10, 2026 as directors through the next annual meeting. Shareholders also voted in favor of the appointment of PricewaterhouseCoopers LLP as the company's auditors and in favor of resolutions amending the c
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2026-09-24 5:30 PM EDT | Medexus Pharmaceuticals Inc.
Phio Pharmaceuticals to Present Clinical Development Update and Upcoming Catalysts at Life Sciences Future 2026 Conference
King of Prussia, Pennsylvania--(Newsfile Corp. - September 23, 2026) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage biopharmaceutical company developing therapeutics using its proprietary INTASYL® siRNA gene silencing technology to eliminate cancer, today announced that it will present at the Life Sciences Future 2026 Conference, taking place September 30 to October 1, 2026, at the Sheraton Valley Forge Hotel in King of Prussia, Pennsylvania. Robert Bitter
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2026-09-23 7:00 AM EDT | Phio Pharmaceuticals Corp.
HEALWELL Expands SMART Summary AI Deployment Across New Brunswick
HEALWELL AI, through its subsidiary Intrahealth Canada Limited ("Intrahealth"), has deployed SMART Summary across New Brunswick, delivering AI-powered clinical summarization directly within Profile, the electronic medical record ("EMR") platform used by front-line providers. Powered by HEALWELL AI's DARWEN clinical AI platform, SMART Summary consolidates a patient's fragmented records into a single structured summary in seconds, reducing the time and cogni
Technology, Healthcare and Hospitals
2026-09-23 6:00 AM EDT | HEALWELL AI
Envoy Medical Announces New Patents, Further Expanding Global Patent Portfolio
White Bear Lake, Minnesota--(Newsfile Corp. - September 22, 2026) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing solutions, today announced the grant of two additional international patents, expanding its global intellectual property portfolio to 97 patents, consisting of 40 U.S. and 57 foreign patents. In addition, the Company has 26 pending foreign applications and 9 pending U.S. applications.
Biotechnology, Healthcare and Hospitals
2026-09-22 8:30 AM EDT | Envoy Medical, Inc.
Adia Med Inc. Announces Adia Labs Biologic Inventory Now Exceeds $1.5 Million to Meet Rising Demand for the Company's Biological Products
Winter Park, Florida--(Newsfile Corp. - September 22, 2026) - Adia Med Inc. (OTCQB: ADIA), a regenerative medicine company focused on stem cell therapies, biologics, and physician-supervised investigational research, today announced that the estimated retail value of biologic inventory at its laboratory division, Adia Labs LLC, now exceeds $1.5 million, driven by accelerating demand for the Company's biologic products as its ongoing clinical studies expand. Management estimates that Adi
Healthcare and Hospitals, Health
2026-09-22 8:00 AM EDT | Adia Med Inc.